Treatment with cisplatin alone did not show any significant (P < 0.05) change in CRP levels; however, treatment with combination of cisplatin with telmisartan showed significant (P < 0.05) decrease in CRP level in cancer treated rats as compared to cancer control rats (Figure 3(a)). This evidence concerns the gene CRP and cancer.